Trials / Not Yet Recruiting
Not Yet RecruitingNCT07057154
Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients
Glycatetd Hemoglobin Index and Red Cell Distribution Width as Prognstic Indicator in Critical Ill Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.
Detailed description
Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units. b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hbg and RDW | Hbg and RDW as prognstic indicator in critical ill patients |
Timeline
- Start date
- 2025-07-05
- Primary completion
- 2026-08-29
- Completion
- 2026-12-02
- First posted
- 2025-07-09
- Last updated
- 2025-07-09
Source: ClinicalTrials.gov record NCT07057154. Inclusion in this directory is not an endorsement.